Registered entities
Fusion Pharmaceuticals Inc.
Reg. No. 1805890United States
FUSIONPHARM, INC.
Reg. No. 1552474United States
Innovation
45 patent families (7 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 630 times.
| Year | Filings |
|---|---|
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 7 |
| 2021 | 11 |
| 2022 | 19 |
| 2023 | 23 |
| 2024 | 34 |
| 2025 | 25 |
| 2026 | 3 |
Investor mix
18 investors on record; lead investors include Johnson & Johnson Innovation, CPP Investments, Adams Street Partners, Seroba Life Sciences; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 56% |
| Private equity | 2 | 11% |
| Other / undisclosed | 6 | 33% |
Hiring activity
Hires occasionally
11 roles tracked across 2 of the last 12 months
27 Dec 2025 · GxP Auditor · Hamilton
11 Dec 2025 · Director, Head of Animal Science & Technologies · Hamilton
11 Dec 2025 · GxP Auditor: GMP Quality & Regulatory Lead · Hamilton
11 Dec 2025 · Validation Associate · Hamilton
11 Dec 2025 · Global Head, Animal Science & Technologies · Hamilton
Based on job postings tracked across public sources.